The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases

J Endocrinol Invest. 2021 Jul;44(7):1363-1377. doi: 10.1007/s40618-021-01502-x. Epub 2021 Jan 26.

Abstract

Cadmium (Cd), a highly toxic heavy metal, is found in soil, environment and contaminated water and food. Moreover, Cd is used in various industrial activities, such as electroplating, batteries production, fertilizers, while an important non-occupational source is represented by cigarette smoking, as Cd deposits in tobacco leaves. Since many years it is clear a strong correlation between Cd body accumulation and incidence of many diseases. Indeed, acute exposure to Cd can cause inflammation and affect many organs such as kidneys and liver. Furthermore, the attention has focused on its activity as environmental pollutant and endocrine disruptor able to interfere with metabolic and energy balance of living beings. Both in vitro and in vivo experiments have demonstrated that the Cd-exposure is related to metabolic diseases such as obesity, diabetes and osteoporosis even if human studies are still controversial. Recent data show that Cd-exposure is associated with atherosclerosis, hypertension and endothelial damage that are responsible for cardiovascular diseases. Due to the large environmental diffusion of Cd, in this review, we summarize the current knowledge concerning the role of Cd in the incidence of metabolic and cardiovascular diseases.

Keywords: Bone; Cadmium; Endocrine disruptors; Metabolic chronic diseases; Obesity.

Publication types

  • Review

MeSH terms

  • Cadmium / adverse effects*
  • Endocrine Disruptors / adverse effects*
  • Humans
  • Metabolic Diseases / etiology
  • Metabolic Diseases / physiopathology*

Substances

  • Endocrine Disruptors
  • Cadmium